Geddes JR, Miklowitz DJ (2013) Bipolar Disorder 3 Treatment of bipolar disorder. Lancet 381(9878):1672–1682
CAS
Article
PubMed
Google Scholar
Freedman R (2003) Schizophrenia. New Engl J Med 349(18):1738–1749
CAS
Article
PubMed
Google Scholar
Gilbert PL, Harris MJ, Mcadams LA, Jeste DV (1995) Neuroleptic withdrawal in schizophrenic-patients—a review of the literature. Arch Gen Psychiatry 52(3):173–188
CAS
Article
PubMed
Google Scholar
Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ (2000) Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 157(2):179–184. https://doi.org/10.1176/appi.ajp.157.2.179
CAS
Article
PubMed
Google Scholar
Viguera AC, Whitfield T, Baldessarini RJ, Newport DJ, Stowe Z, Reminick A, Zurick A, Cohen LS (2007) Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 164(12):1817–1824. https://doi.org/10.1176/appi.ajp.2007.06101639
Article
PubMed
Google Scholar
Reis M, Kallen B (2008) Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharm 28(3):279–288. https://doi.org/10.1097/Jcp.0b013e318172b8d5
CAS
Article
Google Scholar
Kallen B, Tandberg A (1983) Lithium and pregnancy—a cohort study on manic-depressive women. Acta Psychiatry Scand 68(2):134–139. https://doi.org/10.1111/j.1600-0447.1983.tb06991.x
CAS
Article
Google Scholar
Weinstein MR, Goldfield MD (1975) Cardiovascular malformations with lithium use during pregnancy. Am J Psychiatry 132(5):529–531
CAS
Article
PubMed
Google Scholar
Diav-Citrin O, Shechtman S, Tahover E, Finkel-Pekarsky V, Arnon J, Kennedy D, Erebara A, Einarson A, Ornoy A (2014) Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, Observational Study. Am J Psychiatry 171(7):785–794. https://doi.org/10.1176/appi.ajp.2014.12111402
Article
PubMed
Google Scholar
Patorno E, Huybrechts KF, Bateman BT, Cohen JM, Desai RJ, Mogun H, Cohen LS, Hernandez-Diaz S (2017) Lithium Use in Pregnancy and the Risk of Cardiac Malformations. N Engl J Med 376(23):2245–2254. https://doi.org/10.1056/NEJMoa1612222
CAS
Article
PubMed
PubMed Central
Google Scholar
Galbally M, Snellen M, Power J (2014) Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects. Ther Adv Drug Saf 5(2):100–109. https://doi.org/10.1177/2042098614522682
CAS
Article
PubMed
PubMed Central
Google Scholar
Coughlin CG, Blackwell KA, Bartley C, Hay M, Yonkers KA, Bloch MH (2015) Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy. Obstet Gynecol 125(5):1224–1235. https://doi.org/10.1097/AOG.0000000000000759
CAS
Article
PubMed
PubMed Central
Google Scholar
Boden R, Lundgren M, Brandt L, Reutfors J, Andersen M, Kieler H (2012) Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study. BMJ 345:E7085. https://doi.org/10.1136/bmj.e7085
CAS
Article
PubMed
PubMed Central
Google Scholar
Bennedsen BE, Mortensen PB, Olesen AV, Henriksen TB (1999) Preterm birth and intra-uterine growth retardation among children of women with schizophrenia. Br J Psychiatry 175:239–245. https://doi.org/10.1192/bjp.175.3.239
CAS
Article
PubMed
Google Scholar
Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA (2005) Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 162(1):79–91. https://doi.org/10.1176/appi.ajp.162.1.79
Article
PubMed
Google Scholar
Barker DJP (1990) The Fetal and Infant Origins of Adult Disease. BMJ 301(6761):1111–1111
CAS
Article
PubMed Central
PubMed
Google Scholar
Schlotz W, Phillips DI (2009) Fetal origins of mental health: evidence and mechanisms. Brain Behav Immun 23(7):905–916. https://doi.org/10.1016/j.bbi.2009.02.001
Article
PubMed
Google Scholar
Malhi GS, Outhred T (2016) Therapeutic mechanisms of lithium in bipolar disorder: recent advances and current understanding. CNS Drugs 30(10):931–949. https://doi.org/10.1007/s40263-016-0380-1
CAS
Article
PubMed
Google Scholar
Chuang DM, Wang Z, Chiu CT (2011) GSK-3 as a target for lithium-induced neuroprotection against excitotoxicity in neuronal cultures and animal models of ischemic stroke. Front Mol Neurosci 4:15. https://doi.org/10.3389/fnmol.2011.00015
CAS
Article
PubMed
PubMed Central
Google Scholar
Lally J, MacCabe JH (2015) Antipsychotic medication in schizophrenia: a review. Br Med Bull 114(1):169–179. https://doi.org/10.1093/bmb/ldv017 ldv017[pii]
CAS
Article
PubMed
Google Scholar
Kusumi I, Boku S, Takahashi Y (2015) Psychopharmacology of atypical antipsychotic drugs: from the receptor binding profile to neuroprotection and neurogenesis. Psychiatry Clin Neurosci 69(5):243–258. https://doi.org/10.1111/pcn.12242
CAS
Article
PubMed
Google Scholar
Hafeman DM, Chang KD, Garrett AS, Sanders EM, Phillips ML (2012) Effects of medication on neuroimaging findings in bipolar disorder: an updated review. Bipolar Disord 14(4):375–410. https://doi.org/10.1111/j.1399-5618.2012.01023.x
Article
PubMed
Google Scholar
Moncrieff J, Leo J (2010) A systematic review of the effects of antipsychotic drugs on brain volume. Psychol Med 40(9):1409–1422. https://doi.org/10.1017/s0033291709992297
CAS
Article
PubMed
Google Scholar
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med 3(3):e123–130
PubMed
PubMed Central
Google Scholar
Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol 14:43. https://doi.org/10.1186/1471-2288-14-43
Article
PubMed
PubMed Central
Google Scholar
Lo CK, Mertz D, Loeb M (2014) Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol 14:45. https://doi.org/10.1186/1471-2288-14-45
Article
PubMed
PubMed Central
Google Scholar
StataCorp (2017) Stata: Release 15. StataCorp LP, College Station
Google Scholar
Semple BD, Blomgren K, Gimlin K, Ferriero DM, Noble-Haeusslein LJ (2013) Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species. Prog Neurobiol 106–107:1–16. https://doi.org/10.1016/j.pneurobio.2013.04.001
Article
PubMed
Google Scholar
Sechzer JA, Lieberman KW, Alexander GJ (1986) Aberrant parenting and delayed offspring development in rats exposed to lithium. Biol Psychiatry 21(13):1258–1266. https://doi.org/10.1016/0006-3223(86)90308-2
CAS
Article
PubMed
Google Scholar
Abu-Taweel GM (2012) Effects of perinatal exposure of lithium on neuro-behaviour of developing mice offspring. Indian J Exp Biol 50(10):696–701
CAS
PubMed
Google Scholar
Nery LR, Eltz NS, Martins L, Guerim LD, Pereira TC, Bogo MR, Vianna MRM (2014) Sustained behavioral effects of lithium exposure during early development in zebrafish: involvement of the Wnt-(beta)-catenin signaling pathway. Prog Neuro Psychopharmacol Biol Psychiatry 55:101–108. https://doi.org/10.1016/j.pnpbp.2014.04.011
CAS
Article
Google Scholar
Teixeira NA, Lopes RCM, Secoli SR (1995) Developmental toxicity of lithium treatment at prophylactic levels. Braz J Med Biol Res 28(2):230–239
CAS
PubMed
Google Scholar
Rider AA, Simonson M, Weng YS, Hsu JM (1978) Effect on rat pup growth and behavior of maternal lithium ingestion and low protein diet. Nutr Rep Int 17(6):595–605
CAS
Google Scholar
Messiha FS (1986) Lithium and the neonate: developmental and metabolic aspects. Alcohol 3(2):107–112. https://doi.org/10.1016/0741-8329(86)90020-0
CAS
Article
PubMed
Google Scholar
Brain PF, Ajarem JS, Petkov VV (1986) The application of ethopharmacological techniques to behavioural teratology: preliminary investigations. Acta Physiol Pharmacol Bulg 12(4):3–11
CAS
PubMed
Google Scholar
Schou M (1976) What happened later to lithium babies—follow-up-study of children born without malformations. Acta Psychiatry Scand 54(3):193–197. https://doi.org/10.1111/j.1600-0447.1976.tb00112.x
CAS
Article
Google Scholar
Jacobson SJ, Jones K, Johnson K, Ceolin L, Kaur P, Sahn D, Donnenfeld AE, Rieder M, Santelli R, Smythe J, Pastuszak A, Einarson T, Koren G (1992) Prospective multicenter study of pregnancy outcome after lithium exposure during 1st trimester. Lancet 339(8792):530–533. https://doi.org/10.1016/0140-6736(92)90346-5
CAS
Article
PubMed
Google Scholar
van der Lugt NM, van de Maat JS, van Kamp IL, Knoppert-van der Klein EAM, Hovens JGFM, Walther FJ (2012) Fetal, neonatal and developmental outcomes of lithium-exposed pregnancies. Early Hum Dev 88(6):375–378. https://doi.org/10.1016/j.earlhumdev.2011.09.013
CAS
Article
PubMed
Google Scholar
Kozma C (2005) Neonatal toxicity and transient neurodevelopmental deficits following prenatal exposure to lithium: another clinical report and a review of the literature. Am J Med Genet A 132A(4):441–444. https://doi.org/10.1002/ajmg.a.30501
Article
PubMed
Google Scholar
Morrell P, Sutherland GR, Buamah PK, Oo M, Bain HH (1983) Lithium toxicity in a neonate. Arch Dis Child 58(7):539–541
CAS
Article
PubMed Central
PubMed
Google Scholar
Burt VK, Caryn B, Rosenstein WS, Altshuler LL (2010) Bipolar disorder and pregnancy: maintaining psychiatric stability in the real world of obstetric and psychiatric complications. Am J Psychiatry 167(8):892–897. https://doi.org/10.1176/appi.ajp.2009.09081248
Article
PubMed
Google Scholar
Bogen DL, Sit D, Genovese A, Wisner KL (2012) Three cases of lithium exposure and exclusive breastfeeding. Arch Women Ment Health 15:69–72
Article
Google Scholar
Morrell P, Sutherland GR, Buamah PK (1983) Lithium toxicity in a neonate. Arch Dis Child 58(7):539–541
CAS
Article
PubMed Central
PubMed
Google Scholar
Frassetto F, Martel FT, Barjhoux CE, Villier C, Bot BL, Vincent F (2002) Goiter in a newborn exposed to lithium in utero. Ann Pharmacother 36(11):1745–1748
Article
PubMed
Google Scholar
Bruses JL, Berninsone PM, Ojea SI, Azcurra JM (1991) The circling training rat model as a behavioral teratology test. Pharmacol Biochem Behav 38(4):739–745. https://doi.org/10.1016/0091-3057(91)90235-t
CAS
Article
PubMed
Google Scholar
Wolansky MJ, Soiza-Reilly M, Fossati M, Azcurra JM (2004) Postnatal haloperidol eliminates the deficit in circling behavior produced by prenatal exposure to the same drug. Neurotoxicol Teratol 26(4):561–569. https://doi.org/10.1016/j.ntt.2004.04.006
CAS
Article
PubMed
Google Scholar
Archer T, Fredriksson A (1992) Functional changes implicating dopaminergic systems following perinatal treatments. Dev Pharmacol Ther 18(3–4):201–222
CAS
PubMed
Google Scholar
Rosengarten H, Quartermain D (2002) Effect of prenatal administration of haloperidol, risperidone, quetiapine and olanzapine on spatial learning and retention in adult rats. Pharmacol Biochem Behav 72(3):575–579. https://doi.org/10.1016/S0091-3057(02)00727X
CAS
Article
PubMed
Google Scholar
Singh Y, Jaiswal AK, Singh M, Bhattacharya SK (1997) Effect of prenatal haloperidol administration on anxiety patterns in rats. Indian J Exp Biol 35(12):1284–1290
CAS
PubMed
Google Scholar
Spear LP, Shalaby IA, Brick J (1980) Chronic administration of haloperidol during development: behavioral and psychopharmacological effects. Psychopharmacology 70(1):47–58. https://doi.org/10.1007/bf00432369
CAS
Article
PubMed
Google Scholar
Singh KP, Singh M (2002) Effect of prenatal haloperidol exposure on behavioral alterations in rats. Neurotoxicol Teratol 24(4):497–502. https://doi.org/10.1016/s0892-0362(02)00189-7
CAS
Article
PubMed
Google Scholar
Hull EM, Nishita JK, Bitran D, Dalterio S (1984) Perinatal dopamine-related drugs demasculinize rats. Science 224(4652):1011–1013
CAS
Article
PubMed
Google Scholar
Stanford SC (2007) The open field test: reinventing the wheel. J Psychopharmacol 21(2):134–135. https://doi.org/10.1177/0269881107073199
Article
PubMed
Google Scholar
Singh Y, Jaiswal AK, Singh M, Bhattacharya SK (1998) Effect of prenatal diazepam, phenobarbital, haloperidol and fluoxetine exposure on foot shock induced aggression in rats. Indian J Exp Biol 36(10):1023–1024
CAS
PubMed
Google Scholar
Scalzo FM, Ali SF, Holson RR (1989) Behavioral effects of prenatal haloperidol exposure. Pharmacol Biochem Behav 34(4):727–731. https://doi.org/10.1016/0091-3057(89)90266-9
CAS
Article
PubMed
Google Scholar
Williams R, Ali SF, Scalzo FM, Soliman K, Holson RR (1992) Prenatal haloperidol exposure—effects on brain weights and caudate neurotransmitter levels in rats. Brain Res Bull 29(3–4):449–458. https://doi.org/10.1016/0361-9230(92)90082-9
CAS
Article
PubMed
Google Scholar
Myslivecek J, Hassmannova J, Josifko M (1991) Impact of prenatal low-dose diazepam or chlorpromazine on reflex and motor development and inhibitory-learning. Homeost Health Dis 33(1–2):77–88
CAS
PubMed
Google Scholar
Hoffeld DR, McNew J, Webster RL (1968) Effect of tranquilizing drugs during pregnancy on activity of offspring. Nature 218(5139):357–358
CAS
Article
PubMed
Google Scholar
Ordy JM, Samorajski T, Collins RL, Rolsten C (1966) Prenatal chlorpromazine effects on liver, survival and behavior of mice offspring. J Pharmacol Exp Ther 151(1):110–125
CAS
PubMed
Google Scholar
Robertson R, Majka J, Bokelman D (1979) Effects of prenatal exposure to chlorpromazine on postnatal development and behavior of rats. Toxicol Appl Pharmacol 48((1 II)):A117
Google Scholar
Clark CV, Gorman D, Vernadakis A (1970) Effects of prenatal administration of psychotropic drugs on behavior of developing rats. Dev Psychobiol 3(4):225–235
CAS
Article
PubMed
Google Scholar
Umemura T, Hironaka N, Takada K, Sasa H, Yanagita T (1983) Influence of chlorpromazine administered to rat dams in the peripartum and nursing periods on the learning behavior of the second generation. J Toxicol Sci 8(2):105–118
CAS
Article
PubMed
Google Scholar
Jewett RE, Norton S (1966) Effect of tranquilizing drugs on postnatal behavior. Exp Neurol 14(1):33–43
CAS
Article
PubMed
Google Scholar
Szkilnik R, Brus R, Felinska W, Juraszczyk Z, Pyka U, Piechocka J, Kaminski M, Konecki J (1987) Effect of chlorpromazine administered to pregnant and lactating rat females on the behaviour of their offspring and its brain content of bioamines. Acta Med Pol 28(1–4):1–12
CAS
PubMed
Google Scholar
Rosengarten H, Friedhoff AJ (1979) Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats. Science 203(4385):1133–1135
CAS
Article
PubMed
Google Scholar
Singh KP (2015) Prenatal exposure to a novel antipsychotic quetiapine: Impact onneuro-architecture, apoptotic neurodegeneration in fetalhippocampus and cognitive impairment in young rats. Int J Dev Neurosci 42:59–67
CAS
Article
PubMed
Google Scholar
Singh KP, Singh MK, Singh M (2016) Effects of prenatal exposure to antipsychotic risperidone on developmental neurotoxicity, apoptotic neurodegeneration and neurobehavioral sequelae in rat offspring. Int J Dev Neurosci 52:13–23. https://doi.org/10.1016/j.ijdevneu.2016.05.006
CAS
Article
PubMed
Google Scholar
Zuo J, Liu Z, Ouyang X, Liu H, Hao Y, Xu L, Lu XH (2008) Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats. Prog Neuro-Psychopharmacol Biol Psychiatry 32(2):387–397. https://doi.org/10.1016/j.pnpbp.2007.09.005
CAS
Article
Google Scholar
Auerbach JG, Hans SL, Marcus J, Maeir S (1992) Maternal psychotropic medication and neonatal behavior. Neurotoxicol Teratol 14(6):399–406. https://doi.org/10.1016/0892-0362(92)90050-k
CAS
Article
PubMed
Google Scholar
Johnson KC, LaPrairie JL, Brennan PA, Stowe ZN, Newport DJ (2012) Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry 69(8):787–794. https://doi.org/10.1001/archgenpsychiatry.2012.160
Article
PubMed
PubMed Central
Google Scholar
Mortensen JT, Olsen J, Larsen H, Bendsen J, Obel C, Sorensen HT (2003) Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics. Eur J Epidemiol 18(8):769–771. https://doi.org/10.1023/a:1025306304635
CAS
Article
PubMed
Google Scholar
Peng M, Gao K, Ding Y, Ou J, Calabrese JR, Wu R, Zhao J (2013) Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study. Psychopharmacology 228(4):577–584. https://doi.org/10.1007/s00213-013-3060-6
CAS
Article
PubMed
Google Scholar
Platt JE, Friedhoff AJ, Broman SH, Bond R, Laska E, Lin SP (1989) Effects of prenatal neuroleptic drug exposure on motor performance in children. Hum Psychopharmacol 4(3):205–213
Article
Google Scholar
Hurault-Delarue C, Damase-Michel C, Finotto L, Guitard C, Vayssière C, Montastruc JL, Montastruc F, Lacroix I (2016) Psychomotor developmental effects of prenatal exposure to psychotropic drugs: a study in EFEMERIS database. Fundam Clin Pharmacol 30(5):476–482. https://doi.org/10.1111/fcp.12209
CAS
Article
PubMed
Google Scholar
Petersen I, McCrea RL, Sammon CJ, Osborn DP, Evans SJ, Cowen PJ, Freemantle N, Nazareth I (2016) Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records review. Health Technol Assess 20(23):1–176
Article
PubMed Central
PubMed
Google Scholar
Stika L, Elisova K, Honzakova L, Hrochova H, Plechatova H, Strnadova J, Skop B, Svihovec J, Vachova M, Vinar O (1990) Effects of drug administration in pregnancy on children’s school behaviour. Pharm Weekbl Sci 12(6):252–255
CAS
Article
PubMed
Google Scholar
Slone D, Siskind V, Heinonen OP, Monson RR, Kaufman DW, Shapiro S (1977) Antenatal exposure to phenothiazines in relation to congenital-malformations, perinatal mortality-rate, birth-weight, and intelligence quotient score. Am J Obstet Gynecol 128(5):486–488
CAS
Article
PubMed
Google Scholar
Johnson KC, LaPrairie JL, Brennan PA, Stowe ZN, Newport DJ (2012) Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry 69(8):787–794. https://doi.org/10.1001/archgenpsychiatry.2012.160
Article
PubMed
PubMed Central
Google Scholar
Peng M, Gao KM, Ding YL, Ou JJ, Calabrese JR, Wu RR, Zhao JP (2013) Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study. Psychopharmacology 228(4):577–584. https://doi.org/10.1007/s00213-013-3060-6
CAS
Article
PubMed
Google Scholar
Shao P, Ou J, Peng M, Zhao J, Chen J, Wu R (2015) Effects of clozapine and other atypical antipsychotics on infants development who were exposed to as fetus: a post hoc analysis. PLoS One 10(4):e0123373. https://doi.org/10.1371/journal.pone.0123373
CAS
Article
PubMed
PubMed Central
Google Scholar
Cabuk D, Sayin A, Derinoz O, Biri A (2007) Quetiapine use for the treatment of manic episode during pregnancy. Arch Women’s Ment Health 10(5):235–236. https://doi.org/10.1007/s00737-007-0196-6
CAS
Article
Google Scholar
Hammond JE, Toseland PA (1970) Placental transfer of chlorpromazine. Case report. Arch Dis Child 45(239):139–140
CAS
Article
PubMed Central
PubMed
Google Scholar
Janjic V, Milovanovic DR, Ruzic Zecevic D, Loncar D, Laban O, Stepanovic M, Varjacic M, Obradovic S, Dejanovic SD, Jankovic S (2013) Zuclopenthixol decanoate in pregnancy: successful outcomes in two consecutive off springs of the same mother. Vojnosanit Pregl 70(5):526–529. https://doi.org/10.2298/vsp120208005j
Article
PubMed
Google Scholar
Mendhekar DN, Andrade C (2011) Uneventful use of haloperidol and trihehexyphenidyl during three consecutive pregnancies. Arch Women Ment Health 14(1):83–84
CAS
Article
Google Scholar
O’Connor M, Johnson GH, James DI (1981) Intrauterine effects of phenothiazines. Med J Aust 1(8):416–417
PubMed
Google Scholar
Tanaka Y, Takada S, Kuwai T, Kawahara R, Doi K, Hazama H (1990) Psychotropics during pregnancy: serum haloperidol levels measured in 3 patients. Yonago Acta Med 33(1):71–78
Google Scholar
Kenar A, Unal G (2015) Treatment of generalized anxiety diisorder in pregnancy and effects of psychotropic drugs in the infant: a case report. Eur Psychiatry 30:539
Article
Google Scholar
McCauley KM, Cross W, Kulkarni J (2014) Mental health: outcomes of 10 babies of mothers with a history of serious mental illness. J Psychiatry Ment Health Nurs 21(7):580–586. https://doi.org/10.1111/jpm.12111
CAS
Article
Google Scholar
Aichhorn W, Yazdi K, Kralovec K, Steiner H, Whitworth S, Stuppaeck C (2008) Olanzapine plasma concentration in a newborn. J Psychopharmacol 22(8):923–924. https://doi.org/10.1177/0269881107083849
CAS
Article
PubMed
Google Scholar
Kim SW, Kim KM, Kim JM, Shin IS, Shin HY, Yang SJ, Yoon JS (2007) Use of long-acting injectable risperidone before and throughout pregnancy in schizophrenia. Prog Neuro Psychopharmacol Biol Psychiatry 31(2):543–545. https://doi.org/10.1016/j.pnpbp.2006.09.017
CAS
Article
Google Scholar
Mendhekar D, Lohia D (2008) Risperidone therapy in two successive pregnancies. J Neuropsychiatry Clin Neurosci 20(4):485–486
Article
PubMed
Google Scholar
Mendhekar D, Sunder KR, Andrade C (2006) Aripiprazole use in a pregnant schizoaffective woman. Bipolar Disord 8(3):299–300. https://doi.org/10.1111/j.1399-5618.2006.00316.x
CAS
Article
PubMed
Google Scholar
Ratnayake T, Libretto SE (2002) No complications with risperidone treatment before and throughout pregnancy and during the nursing period. J Clin Psychiatry 63(1):76–77. https://doi.org/10.4088/JCP.v63n0114c
CAS
Article
PubMed
Google Scholar
Rowe M, Gowda BA, Taylor D, Hannam S, Howard LM (2012) Neonatal hypoglycaemia following maternal olanzapine therapy during pregnancy: a case report. Ther Adv Psychopharmacol 2(6):265–268. https://doi.org/10.1177/2045125312460395
Article
PubMed
PubMed Central
Google Scholar
Stiegler A, Schaletzky R, Walter G, Wust R, Abele H, Goelz R, Farger G, Wiatr G, Fallgatter AJ, Batra A (2014) Olanzapine treatment during pregnancy and breastfeeding: a chance for women with psychotic illness? Psychopharmacology 231(15):3067–3069. https://doi.org/10.1007/s00213-014-3647-6
CAS
Article
PubMed
Google Scholar
Tenyi T, Trixler M, Keresztes Z (2002) Quetiapine and pregnancy. Am J Psychiatry 159(4):674. https://doi.org/10.1176/appi.ajp.159.4.674
Article
PubMed
Google Scholar
Werremeyer A (2009) Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression. Am J Psychiatry 166(11):1298. https://doi.org/10.1176/appi.ajp.2009.09060765
Article
PubMed
Google Scholar
Rodríguez FJZ, Vega B, Hernández MRSW, Macías JAG, Leal FJV (2017) Use of paliperidone palmitate throughout a schizoaffective disorder patient’s gestation period. Pharmacopsychiatry 50(1):38–40. https://doi.org/10.1055/s-0042-110492
Article
Google Scholar
Barnas C, Bergant A, Hummer M, Saria A, Fleischhacker W (1994) Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk. Am J Psychiatry 151(6):945
CAS
Article
PubMed
Google Scholar
Klier CM, Mossaheb N, Saria A, Schloegelhofer M, Zernig G (2007) Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum. J Clin Psychopharmacol 27(6):720–722. https://doi.org/10.1097/JCP.0b013e31815a57d8
Article
PubMed
Google Scholar
Gentile S (2015) Pharmacological management of borderline personality disorder in a pregnant woman with a previous history of alcohol addiction: a case report. Clin Drug Investig 35(11):761–763. https://doi.org/10.1007/s40261-015-0337-z
Article
PubMed
Google Scholar
Mendhekar DN (2007) Possible delayed speech acquisition with clozapine therapy during pregnancy and lactation [4]. J Neuropsychiatry Clin Neurosci 19(2):196–197. https://doi.org/10.1176/appi.neuropsych.19.2.196
CAS
Article
PubMed
Google Scholar
Wichman CL (2009) Atypical antipsychotic use in pregnancy: a retrospective review. Arch Women’s Ment Health 12(1):53–57. https://doi.org/10.1007/s00737-008-0044-3
Article
Google Scholar
Dabbert D, Heinze M (2006) Follow-up of a pregnancy with risperidone microspheres. Pharmacopsychiatry 39(6):235. https://doi.org/10.1055/s-2006-951387
CAS
Article
PubMed
Google Scholar
Karakula H, Szajer K, Spila B, Grzywa A, Chuchra M (2004) Clozapine and pregnancy: a case history. Pharmacopsychiatry 37(6):303–304. https://doi.org/10.1055/s-2004-832689
CAS
Article
PubMed
Google Scholar
Stingl J, Berghöfer A, Bolk-Weischedel D (2000) Healthy outcome under olanzapine treatment in a pregnant woman. Pharmacopsychiatry 33:78–80
Article
Google Scholar
Schou M, Goldfield MD, Weinstein MR, Villeneuve A (1973) Lithium and pregnancy. I. report from the register of lithium babies. BMJ 2(5859):135–136
CAS
Article
PubMed
Google Scholar
National collaborating centre for mental H (2014). doi: NBK305023 [bookaccession]
ACOG Committee on Practice Bulletins–Obstetrics (2008) ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 111(4):1001–1020. https://doi.org/10.1097/AOG.0b013e31816fd910
Article
Google Scholar
Escudero I, Johnstone M (2014) Genetics of Schizophrenia. Curr Psychiatry Rep 16(11):502. https://doi.org/10.1007/s11920-014-0502-8
Article
PubMed
Google Scholar
Seifuddin F, Pirooznia M, Judy JT, Goes FS, Potash JB, Zandi PP (2013) Systematic review of genome-wide gene expression studies of bipolar disorder. BMC Psychiatry 13:213. https://doi.org/10.1186/1471-244x-13-213
Article
PubMed
PubMed Central
Google Scholar
Scott S (2012) Parenting quality and children’s mental health: biological mechanisms and psychological interventions. Curr Opin Psychiatry 25(4):301–306. https://doi.org/10.1097/Yco.0b013e328354a1c5
Article
PubMed
Google Scholar
Leijdesdorff S, van Doesum K, Popma A, Klaassen R, van Amelsvoort T (2017) Prevalence of psychopathology in children of parents with mental illness and/or addiction: an up to date narrative review. Curr Opin Psychiatry 30(4):312–317. https://doi.org/10.1097/YCO.0000000000000341
Article
PubMed
Google Scholar
Maziade M, Rouleau N, Gingras N, Boutin P, Paradis ME, Jomphe V, Boutin J, Letourneau K, Gilbert E, Lefebvre AA, Dore MC, Marino C, Battaglia M, Merette C, Roy MA (2009) Shared neurocognitive dysfunctions in young offspring at extreme risk for schizophrenia or bipolar disorder in eastern quebec multigenerational families. Schizophr Bull 35(5):919–930. https://doi.org/10.1093/schbul/sbn058
Article
PubMed
Google Scholar
Diwadkar VA, Goradia D, Hosanagar A, Mermon D, Montrose DM, Birmaher B, Axelson D, Rajarathinem R, Haddad L, Amirsadri A, Zajac-Benitez C, Rajan U, Keshavan MS (2011) Working memory and attention deficits in adolescent offspring of schizophrenia or bipolar patients: comparing vulnerability markers. Prog Neuropsychopharmacol Biol Psychiatry 35(5):1349–1354. https://doi.org/10.1016/j.pnpbp.2011.04.009
Article
PubMed
PubMed Central
Google Scholar
Jundong J, Kuja-Halkola R, Hultman C, Langstrom N, D’Onofrio BM, Lichtenstein P (2012) Poor school performance in offspring of patients with schizophrenia: what are the mechanisms? Psychol Med 42(1):111–123. https://doi.org/10.1017/S0033291711001127
CAS
Article
PubMed
Google Scholar
Burton BK, Thorup AAE, Jepsen JR, Poulsen G, Ellersgaard D, Spang KS, Christiani CJ, Hemager N, Gantriis D, Greve A, Mors O, Nordentoft M, Plessen KJ (2017) Impairments of motor function among children with a familial risk of schizophrenia or bipolar disorder at 7 years old in Denmark: an observational cohort study. Lancet Psychiatry 4(5):400–408. https://doi.org/10.1016/s2215-0366(17)30103-7
Article
PubMed
Google Scholar
Nery FG, Norris M, Eliassen JC, Weber WA, Blom TJ, Welge JA, Barzman DA, Strawn JR, Adler CM, Strakowski SM, DelBello MP (2017) White matter volumes in youth offspring of bipolar parents. J Affect Disord 209:246–253. https://doi.org/10.1016/j.jad.2016.11.023
Article
PubMed
Google Scholar
Hanford LC, Hall GB, Minuzzi L, Sassi RB (2016) Gray matter volumes in symptomatic and asymptomatic offspring of parents diagnosed with bipolar disorder. Eur Child Adolesc Psychiatry 25(9):959–967. https://doi.org/10.1007/s00787-015-0809-y
Article
PubMed
Google Scholar
de Leeuw M, Bohlken MM, Mandl RC, Hillegers MH, Kahn RS, Vink M (2017) Changes in White Matter Organization in Adolescent Offspring of Schizophrenia Patients. Neuropsychopharmacology 42(2):495–501. https://doi.org/10.1038/npp.2016.130
Article
PubMed
Google Scholar
Sugranyes G, de la Serna E, Romero S, Sanchez-Gistau V, Calvo A, Moreno D, Baeza I, Diaz-Caneja CM, Sanchez-Gutierrez T, Janssen J, Bargallo N, Castro-Fornieles J (2015) Gray matter volume decrease distinguishes schizophrenia from bipolar offspring during childhood and adolescence. J Am Acad Child Adolesc Psychiatry. 54(8):677–684 e672. https://doi.org/10.1016/j.jaac.2015.05.003
Article
PubMed
Google Scholar
Egger M, Smith GD (1998) Bias in location and selection of studies. BMJ 316(7124):61–66
CAS
Article
PubMed Central
PubMed
Google Scholar
Kapur S, Wadenberg ML, Remington G (2000) Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the bench. Can J Psychiatry 45(3):241–246. https://doi.org/10.1177/070674370004500302
CAS
Article
PubMed
Google Scholar
Institute of Medicine (2012) In: Ethical and scientific issues in studying the safety of approved drugs. National Academies Press, Washington. https://doi.org/10.17226/13219
Book
Google Scholar
Guess HA (2006) Exposure-time-varying hazard function ratios in case-control studies of drug effects. Pharmacoepidemiol Drug Saf 15(2):81–92. https://doi.org/10.1002/pds.1164
Article
PubMed
Google Scholar